COVID-19 DNA Solutions

COVID-19 DNA Solutions

Bio-Manufacturing

Information

Since the outbreak of COVID-19, Synbio Technologies has set up a special coronavirus emergency project team, working against time to produce virus-related probes, genes, and protein products. We are currently providing comprehensive COVID-19 DNA solutions and working with our clients and partners from hospitals, scientific research institutes, and enterprises to fight the disease. This includes probe synthesis, gene synthesis, protein expression, and antibody discovery services for SARS-CoV-2. SARS-CoV-2 Detection Assay Kits are also available.
Synbio TechnologiesFounded in 2013 by a group of passionate synthetic biologists with decades of industry experience and a proven track record of delivering cost-effective DNA solutions, Synbio Technologies is incorporated with a single mission in mind- to empower scientific discoveries and drug innovation by providing the most advanced and cost-effective DNA technology platform. The company has developed a full range of DNA reading (sequencing), DNA writing (synthesis) and DNA editing (engineering) capabilities and delivered satisfactory solutions to global researchers for various applications such as diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, etc. Synbio Technologies has over 250 scientific staff and its state-of-the-art production facility is certified with the highest DNA manufacturing standards (ISO9001 & ISO13485).

Log in